Seelos Therapeutics to Participate in Two Upcoming Investor Conferences in March
2020年2月19日 - 10:02PM
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage
biopharmaceutical company focused on the development of therapies
for central nervous system disorders and rare diseases, today
announced that it will participate in two upcoming investor
conferences in March 2020.
Raj Mehra, Ph.D., Chairman and CEO, will present at the Cowen
40th Annual Health Care Conference on Wednesday, March 4th at
8:40am ET.
The live audio webcast of the presentation can be accessed at:
http://wsw.com/webcast/cowen57/seel/
Please note that this replay will be available for 90 days
following the presentation.
Dr. Mehra will also participate at the Roth Capital 32nd Annual
Conference and present on Tuesday, March 17th at 8:00am PT.
About Seelos Therapeutics:
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical
company focused on the development and advancement of novel
therapeutics to address unmet medical needs for the benefit of
patients with central nervous system (CNS) disorders and other rare
diseases. The Company's robust portfolio includes several
late-stage clinical assets targeting indications including Acute
Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder
(MDD) or Post-Traumatic Stress Disorder (PTSD), Sanfilippo
syndrome, Parkinson’s Disease, other psychiatric and movement
disorders plus orphan diseases.
For more information, please visit our website:
http://seelostherapeutics.com, the content of which is not
incorporated herein by reference.
Contact Information:
Anthony Marciano Head of Corporate Communications Seelos
Therapeutics, Inc. (Nasdaq: SEEL) 300 Park Ave., 12th Fl New York,
NY 10022 (646) 293-2136
anthony.marciano@seelostx.comhttps://seelostherapeutics.com/https://twitter.com/seelostxhttps://www.linkedin.com/company/seelos
Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 6 2024 まで 7 2024
Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 7 2023 まで 7 2024